Á lódáil...
Risk factors in multiple myeloma: is it time for a revision?
Although therapeutic strategies have been adapted to age and comorbidities for a long time, almost all multiple myeloma (MM) patients currently receive similar treatment, whatever their disease risk category. However, high-risk MM patients still constitute an unmet medical need and should benefit fr...
Na minha lista:
| Foilsithe in: | Blood |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Society of Hematology
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7808011/ https://ncbi.nlm.nih.gov/pubmed/33024991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004309 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|